The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Response to milk thistle among people with hepatitis C

    Researchers in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial looked at the use and response to silymarin (milk thistle extract) among the patients in the study.

    The study was not designed to evaluate milk thistle, but here’s what they found.

    • Among all participants, 17% (about 190 people) were taking silymarin at the start of the study.
    • Blood levels of alanine aminotransferase (an enzyme that may indicate liver damage) did not change with silymarin use.
    • Hepatitis C virus (HCV; the virus that causes hepatitis [inflammation of the liver]) levels did not change with silymarin use.
    • However, there were significantly fewer liver-related symptoms and better quality-of-life in users than non-users.

    The bottom line?
    If a lab value doesn’t change but the patient feels better, is it worth including in the treatment regimen?

    12/25/07 13:55 JR

    Leave a Comment

    You must be logged in to post a comment.